Clinical Trials List
2021-12-01 - 2026-11-30
Phase III
Recruiting6
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 劉奕廷 Division of Hematology & Oncology
- Chih-Chieh Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Shen 無
- Po-Jung Su 無
- Wen-Chi Chou 無
- 吳教恩 無
- 陳弘吉 無
- Hung-Chih Hsu 無
- 黃文冠 無
- Cheng-Lung Hsu 無
- Tsai-Sheng Yang 無
- Ming-Mo Hou 無
- 余紹銘 無
- Chan-Keng Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王秀慈 無
- Chang-Fang Chiu 無
- Che-Hung Lin 無
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yen-Cheng Chen 無
- 黃敬文 無
- 蔡祥麟 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
19 participants
-
Global
516 participants
